… development, especially focusing on inflammatory cytokines. We also summarize the
clinical trials for gene therapy targeting inflammatory cytokines for cancer treatment. Future …

… activities of several pro-inflammatory cytokines in animal models, clinical research led to the
… However, the clinical development of this cytokine is still in its infancy and progress is likely …

… Several clinical trials targeting inflammatory cytokines in CRC have been initiated. A …
inflammatory cytokines in prostate cancer progression may provide an optimized targeted-therapy …

… development, especially focusing on inflammatory cytokines. We also summarize the
clinical trials for gene therapy targeting inflammatory cytokines for cancer treatment. Future …

… We also discuss recent progress in methods for improving the delivery efficiency, stability, …
As the sole type II IFN, IFN-γ is a typical pro-inflammatory cytokine that exerts antitumor effects …

… For the patient, the aim of therapy is to block the inflammatory effects of these cytokines. For
… and progression of cancer, we can use the examples of the pro-inflammatory cytokines such …

… cytokines in the progression of breast cancer. Obesity is associated with elevated levels of
proinflammatory cytokines … receptors, accelerated clinical progression, and metastasis: poor …

… attenuate metastatic progression. We review clinical trials targeting different inflammatory
cytokines in patients with metastatic cancers. Due to the pleiotropy and redundancy of pro-…

… cancer therapy, gastric cancer is still the most lethal cancer in … strategies, clinical trials of
cytokine-based therapy have been … However, proinflammatory or anti-inflammatory treatments …

… with pancreatic cancer risk and progression in a number of clinical, epidemiological, and …
plasma markers of inflammation associated with survival of pancreatic cancer patients, and …